SXTP Drops −34% in Snapshot as Warrant Deal Raises Dilution Questions
60 Degrees Pharmaceuticals disclosed a discounted warrant exercise agreement. Explore the new financing, additional warrants and risks behind the SXTP decline.
Read the story
60 Degrees Pharmaceuticals disclosed a discounted warrant exercise agreement. Explore the new financing, additional warrants and risks behind the SXTP decline.
Read the story